Follow this preprint
Two doses of the mRNA BNT162b2 vaccine reduce severe outcomes, viral load and secondary attack rate: evidence from a SARS-CoV-2 Alpha outbreak in a nursing home in Germany, January-March 2021
View ORCID ProfileEmily Dorothee Meyer, View ORCID ProfileMirco Sandfort, View ORCID ProfileJennifer Bender, View ORCID ProfileDorothea Matysiak-Klose, View ORCID ProfileAchim Dörre, View ORCID ProfileGerhard Bojara, View ORCID ProfileKonrad Beyrer, View ORCID ProfileWiebke Hellenbrand
doi: https://doi.org/10.1101/2021.09.13.21262519
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Emily Dorothee Meyer
1Department of Infectious Disease Epidemiology, Postgraduate Training for Applied Epidemiology (PAE), Robert Koch Institute, Berlin, Germany
2European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
Mirco Sandfort
1Department of Infectious Disease Epidemiology, Postgraduate Training for Applied Epidemiology (PAE), Robert Koch Institute, Berlin, Germany
2European Programme for Intervention Epidemiology Training (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
Jennifer Bender
4Department of Infectious Diseases, Nosocomial Pathogens and Antibiotic Resistances Unit, Robert Koch Institute, Berlin, Germany
5European Programme for Public Health Microbiology Training (EUPHEM), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden
Dorothea Matysiak-Klose
6Department of Infectious Disease Epidemiology, Immunization Unit, Robert Koch Institute, Berlin, Germany
Achim Dörre
1Department of Infectious Disease Epidemiology, Postgraduate Training for Applied Epidemiology (PAE), Robert Koch Institute, Berlin, Germany
Gerhard Bojara
7Local Public Health Authority Osnabrück
Konrad Beyrer
8Department of Infectious Diseases, Public Health Agency of Lower Saxony
Wiebke Hellenbrand
6Department of Infectious Disease Epidemiology, Immunization Unit, Robert Koch Institute, Berlin, Germany
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Article usage
Picked up by 1 news outlets
Referenced in 1 policy documents
Tweeted by 12
Posted September 23, 2021.
Two doses of the mRNA BNT162b2 vaccine reduce severe outcomes, viral load and secondary attack rate: evidence from a SARS-CoV-2 Alpha outbreak in a nursing home in Germany, January-March 2021
Emily Dorothee Meyer, Mirco Sandfort, Jennifer Bender, Dorothea Matysiak-Klose, Achim Dörre, Gerhard Bojara, Konrad Beyrer, Wiebke Hellenbrand
medRxiv 2021.09.13.21262519; doi: https://doi.org/10.1101/2021.09.13.21262519
This article is a preprint and has not been peer-reviewed [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
Subject Area
Subject Areas
- Addiction Medicine (408)
- Allergy and Immunology (720)
- Anesthesia (214)
- Cardiovascular Medicine (3045)
- Dermatology (258)
- Emergency Medicine (456)
- Epidemiology (12963)
- Forensic Medicine (12)
- Gastroenterology (849)
- Genetic and Genomic Medicine (4778)
- Geriatric Medicine (441)
- Health Economics (747)
- Health Informatics (3031)
- Health Policy (1097)
- Hematology (405)
- HIV/AIDS (953)
- Medical Education (450)
- Medical Ethics (119)
- Nephrology (492)
- Neurology (4549)
- Nursing (243)
- Nutrition (672)
- Oncology (2366)
- Ophthalmology (667)
- Orthopedics (264)
- Otolaryngology (332)
- Pain Medicine (297)
- Palliative Medicine (86)
- Pathology (512)
- Pediatrics (1232)
- Primary Care Research (515)
- Public and Global Health (7140)
- Radiology and Imaging (1588)
- Respiratory Medicine (941)
- Rheumatology (456)
- Sports Medicine (396)
- Surgery (506)
- Toxicology (63)
- Transplantation (218)
- Urology (187)